Value of FDG PET in patients with fever of unknown origin

Citation
J. Lorenzen et al., Value of FDG PET in patients with fever of unknown origin, NUCL MED C, 22(7), 2001, pp. 779-783
Citations number
19
Categorie Soggetti
Radiology ,Nuclear Medicine & Imaging
Journal title
NUCLEAR MEDICINE COMMUNICATIONS
ISSN journal
01433636 → ACNP
Volume
22
Issue
7
Year of publication
2001
Pages
779 - 783
Database
ISI
SICI code
0143-3636(200107)22:7<779:VOFPIP>2.0.ZU;2-P
Abstract
Fever of unknown origin (FUO) is a diagnostic challenge, because the cause of such fer er may be manifold. Studies on the use of positron emission tom ography (PET) using F-18-fluorodeoxyglucose (F-18-FDG), for the diagnosis o f inflammation in patients with osteomyelitis or HIV have been promising an d suggest its use in patients with FUO. In this study, we used FDG PET in 1 6 patients with FUO in whom conventional diagnostics had not been conclusiv e. In 12 patients, (75%) non-physiological accumulations of FDG were found which led to the final diagnosis in 11 patients (69%). FDG PET was negative in four patients (25%). Two of these patients had rheumatic fever, while i n the other two patients the origin of fever could not be detected within 3 months after PET by any other laboratory or imaging means. These findings point to the high sensitivity of FDG whole-body PET for the detection of mo rphologically assessable foci as an origin of FUO. Moreover, they suggest a high negative predictive value of FDG PET in the setting of FUO, since in no patient with a negative FDG PET could a morphological origin of the feve r be determined. In conclusion, FDG whole-body PET appears to be a promisin g diagnostic tool in patients with FUO, in whom conventional diagnostics ha d been unsuccessful. ((C) 2001 Lippincott Williams & Wilkins).